GB1401565A - Vaccine for neonatal calf diarrhoea - Google Patents
Vaccine for neonatal calf diarrhoeaInfo
- Publication number
- GB1401565A GB1401565A GB4925373A GB4925373A GB1401565A GB 1401565 A GB1401565 A GB 1401565A GB 4925373 A GB4925373 A GB 4925373A GB 4925373 A GB4925373 A GB 4925373A GB 1401565 A GB1401565 A GB 1401565A
- Authority
- GB
- United Kingdom
- Prior art keywords
- vaccine
- bovine
- virus
- coronavirus
- diarrhea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30217972A | 1972-10-30 | 1972-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1401565A true GB1401565A (en) | 1975-07-16 |
Family
ID=23166611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB4925373A Expired GB1401565A (en) | 1972-10-30 | 1973-10-23 | Vaccine for neonatal calf diarrhoea |
Country Status (17)
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0246680A1 (en) * | 1986-04-21 | 1987-11-25 | Akzo Nobel N.V. | Combined vaccine |
| WO1990001337A1 (en) * | 1988-08-03 | 1990-02-22 | Institute For Animal Health Limited | Vaccine |
| US6416764B1 (en) | 1988-08-03 | 2002-07-09 | Vericore Limited | Vaccine |
| US10808227B2 (en) | 2015-11-06 | 2020-10-20 | Asahi Kasei Medical Co., Ltd. | Method for producing parvovirus having high infectivity titer and high purity |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6027007U (ja) * | 1983-07-30 | 1985-02-23 | 株式会社 協立双葉自動機 | 容器回転速度調整装置付きラベリングマシン |
| JPH0518338Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1985-12-27 | 1993-05-17 | ||
| JPH08786B2 (ja) * | 1993-02-25 | 1996-01-10 | 株式会社微生物化学研究所 | 牛コロナウイルス感染症ワクチン |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE759425A (fr) * | 1969-11-28 | 1971-05-25 | Mebus Charles A | Vaccins contre la diarrhee du veau, leur preparation et emploi |
| US3629413A (en) * | 1970-02-04 | 1971-12-21 | Univ Southern Illinois | Polyvalent bovine vaccines and methods of making and using same |
-
1973
- 1973-10-16 SE SE7314001A patent/SE419500B/xx unknown
- 1973-10-17 NL NL7314293A patent/NL7314293A/xx unknown
- 1973-10-23 AR AR250655A patent/AR200155A1/es active
- 1973-10-23 GB GB4925373A patent/GB1401565A/en not_active Expired
- 1973-10-24 AU AU61774/73A patent/AU476160B2/en not_active Expired
- 1973-10-26 DD DD174314A patent/DD110517A5/xx unknown
- 1973-10-26 IE IE1925/73A patent/IE38423B1/xx unknown
- 1973-10-26 ES ES419996A patent/ES419996A1/es not_active Expired
- 1973-10-26 BE BE137108A patent/BE806568A/xx not_active IP Right Cessation
- 1973-10-29 FI FI733344A patent/FI52740C/fi active
- 1973-10-29 ZA ZA738329A patent/ZA738329B/xx unknown
- 1973-10-29 CA CA184,534A patent/CA1019675A/en not_active Expired
- 1973-10-29 CH CH1521373A patent/CH596315A5/xx not_active IP Right Cessation
- 1973-10-30 FR FR7338701A patent/FR2204405B1/fr not_active Expired
- 1973-10-30 JP JP48122156A patent/JPS5817169B2/ja not_active Expired
- 1973-10-30 HU HU73BO1469A patent/HU168486B/hu unknown
- 1973-10-30 DE DE2354324A patent/DE2354324C2/de not_active Expired
-
1978
- 1978-10-13 JP JP12675178A patent/JPS5531058A/ja active Granted
-
1981
- 1981-12-28 JP JP56215939A patent/JPS57131726A/ja active Granted
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0246680A1 (en) * | 1986-04-21 | 1987-11-25 | Akzo Nobel N.V. | Combined vaccine |
| WO1990001337A1 (en) * | 1988-08-03 | 1990-02-22 | Institute For Animal Health Limited | Vaccine |
| GB2239799A (en) * | 1988-08-03 | 1991-07-17 | Animal Health Inst | Vaccine |
| GB2239799B (en) * | 1988-08-03 | 1992-01-22 | Animal Health Inst | Vaccine |
| US6416764B1 (en) | 1988-08-03 | 2002-07-09 | Vericore Limited | Vaccine |
| US10808227B2 (en) | 2015-11-06 | 2020-10-20 | Asahi Kasei Medical Co., Ltd. | Method for producing parvovirus having high infectivity titer and high purity |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2179105T3 (es) | Adyuvantes proteinicos. | |
| IT1190792B (it) | Procedimento per preparare composizioni di enzimi coagulanti del sangue | |
| DK26081A (da) | Genetisk svaekkede bakterievacciner med multiple mutationer af samme faenotype | |
| GB1401565A (en) | Vaccine for neonatal calf diarrhoea | |
| IT1044555B (it) | Benzodipironi e procedimento per prepararli | |
| SE7512828L (sv) | Calicivirusvaccin | |
| ES477212A1 (es) | Un procedimiento para la preparacion de una enterotoxina. | |
| TW340873B (en) | Chicken anaemia agent vaccine | |
| ES370327A1 (es) | Procedimiento para la preparacion de vacunas protectores contra infecciones intestinales locales, polivalentes, sus- ceptibles de ser aplicadas oralmente. | |
| DE3361138D1 (en) | Ozone inactivated organisms as vaccines | |
| NL300073I1 (nl) | Vaccin. | |
| SE7711433L (sv) | Tricykliska foreningar | |
| GB949400A (en) | Poliomyelitis vaccines | |
| SU565653A1 (ru) | Способ консервировани костной ткани | |
| GB1065899A (en) | Improvements in or relating to martensitic,age hardening stainless steel | |
| SU979504A1 (ru) | Щтамм НАГ-фага 93,Ф-98,лизирующий НАГ-вибрионы 0-8 серотипа | |
| ES279927A1 (es) | Procedimiento de preparaciën de una vacuna contra la fiebre aftosa | |
| Saben | Rapeseed meal as an energy and protein source for growing pigs | |
| GB1323842A (en) | Immunizing vaccine for the immunization of dogs against kennel cough | |
| GB414639A (en) | Improvements in and relating to a process for hardening wood which has been rendered easily flexible | |
| Nicolas et al. | Attempt of Vaccination Program Against Sheep Salmonellosis due to Salmonella abortus ovis. | |
| GB949399A (en) | Poliomyelitis vaccines | |
| JPS53109912A (en) | Condensed tannin, inactivation of microorganism-originated toxic substance, and attenuation of vaccines using condensed tannin | |
| ES342709A1 (es) | Un prodecimiento para preparar una vacuna de cerdo inacti- vada para el colera. | |
| DK49685A (da) | Fremgangsmaade til fremstilling af en modificeret levende pasteurella haemolytica vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PE20 | Patent expired after termination of 20 years |
Effective date: 19931022 |